Yushuai Yu

fujian medical university

H指数:6

被引数:141

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Machine Learning-driven Prognostic Stratification in Metastatic Breast Cancer Using Dynamic ¹⁸F-FDG PET/CT: A Multidimensional Study Integrating Pathomics and Plasma Proteomics

机器学习驱动的转移性乳腺癌预后分层：基于动态<sup>18</sup>F-FDG PET/CT的多维度研究，整合病理组学和血浆蛋白质组学

Academic Radiology

IF3.9

2026-10-010

PET/CT-based quantification of intratumoral heterogeneity for predicting pathological complete response in breast cancer patients treated with neoadjuvant chemotherapy: A multicentre study

基于PET/CT的肿瘤内异质性定量预测乳腺癌新辅助化疗患者病理完全缓解的多中心研究

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2026-02-170

PRE

Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer

预测三阴性乳腺癌三级淋巴结构和治疗反应的机器学习模型

npj Precision Oncology

IF8

2025-07-010

PREAI

Integrated single-cell and bulk transcriptomic analysis identifies a novel macrophage subtype associated with poor prognosis in breast cancer

整合单细胞与bulk转录组分析识别出一种与乳腺癌不良预后相关的巨噬细胞新亚型

CANCER CELL INTERNATIONAL

IF6

2025-03-270

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer

CANCER CELL INTERNATIONAL

IF6

2025-01-180

OAAI

Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer

BRITISH JOURNAL OF CANCER

IF6.8

2024-12-100

PRE

Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data

BREAST

IF7.9

2024-10-011

OAAI

Predictive model of prognosis index for invasive micropapillary carcinoma of the breast based on machine learning: a SEER population-based study

基于机器学习的乳腺浸润性微乳头状癌预后指标预测模型: 一项基于SEER人群的研究

BMC MEDICAL INFORMATICS AND DECISION MAKING

IF3.8

2024-09-271

OAAI

Unraveling the causal links and novel molecular classification of Crohn's disease in breast Cancer: a two-sample mendelian randomization and transcriptome analysis with prognostic modeling

BMC CANCER

IF3.4

2024-09-110

OAAI

Does T1c-2N0-1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Predictive Modeling for Identifying Breast Cancer Patients Eligible for Axillary Lymph Node Dissection Exemption Following Neoadjuvant Therapy: A Longitudinal MRI-based Radiomics and Deep Learning Features Analysis

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Efficacy and Safety of First-line Therapy in Patients with HER-2 positive Advanced Breast Cancer: A network Meta-analysis of Randomized Controlled Trials

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Clinical significance and immune landscape analyses of the immune related genes based prognostic signature for HER2 positive breast cancer

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study

70岁及以上男性乳腺癌患者辅助化疗与生存: 一项基于人群的回顾性研究

BMC GERIATRICS

IF3.8

2024-03-250

OAAI

The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis

BMC CANCER

IF3.4

2024-01-020

OAAI

Epidemiology and a Predictive Model of Prognosis Index Based on Machine Learning in Primary Breast Lymphoma: Population-Based Study

JMIR PUBLIC HEALTH AND SURVEILLANCE

IF3.9

2023-06-082

OAAI

The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database

通过机器学习对早期老年三阴性乳腺癌 (eTNBC) 的化疗和生存预测的影响: 来自SEER数据库的基于人群的研究

BMC GERIATRICS

IF3.8

2022-04-0120

OAAI

The impact of chemotherapy in elderly early triple negative breast cancer: A population based study from the SEER database

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Efficacy and safety of neoadjuvant therapy for HER2-positive early breast cancer: a network meta-analysis

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2021-04-0312

OAAI

Yushuai Yu

个人简介

教育背景

工作经历

荣誉奖项

研究方向